Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26649656.
- Also identified by DOI 10.1038/ki.2015.328 and PMC identifier 5267352.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The transcription factor Nrf2 plays an important role in many kidney diseases from acute kidney injury to chronic kidney disease, and there have been preliminary Nrf2-based therapeutic trials in humans. Shelton et al. presents an integrated transcriptomic and proteomic analysis of mouse kidney to reveal Nrf2 targets with potentially important roles in kidney homeostasis and pathophysiology. These results can further our understanding of Nrf2-based mechanisms and help in the development of therapeutics for a wide range of kidney diseases.